Bank of New York Mellon’s Ascendis Pharma A/S ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $52.3M | Buy |
|
|||||
|
2025
Q4 | $41.5M | Sell |
|
|||||
|
2025
Q3 | $41.6M | Buy |
|
|||||
|
2025
Q2 | $20.3M | Buy |
|
|||||
|
2025
Q1 | $13.9M | Sell |
|
|||||
|
2024
Q4 | $13.5M | Sell |
|
|||||
|
2024
Q3 | $15.7M | Sell |
|
|||||
|
2024
Q2 | $15.1M | Sell |
|
|||||
|
2024
Q1 | $22.8M | Sell |
|
|||||
|
2023
Q4 | $26.8M | Sell |
|
|||||
|
2023
Q3 | $21.8M | Sell |
|
|||||
|
2023
Q2 | $28.2M | Buy |
|
|||||
|
2023
Q1 | $26.3M | Sell |
|
|||||
|
2022
Q4 | $30.6M | Sell |
|
|||||
|
2022
Q3 | $27M | Sell |
|
|||||
|
2022
Q2 | $25.1M | Sell |
|
|||||
|
2022
Q1 | $34M | Buy |
|
|||||
|
2021
Q4 | $32.3M | Sell |
|
|||||
|
2021
Q3 | $38.6M | Sell |
|
|||||
|
2021
Q2 | $34.6M | Buy |
|
|||||
|
2021
Q1 | $33.9M | Buy |
|
|||||
|
2020
Q4 | $27M | Buy |
|
|||||
|
2020
Q3 | $23.5M | Buy |
|
|||||
|
2020
Q2 | $20.3M | Buy |
|
|||||
|
2020
Q1 | $14.3M | Sell |
|
|||||
|
2019
Q4 | $18.7M | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $7.73M | Buy |
|